Research Article
Clinical Evaluation of FOXO1 as a Tumor Suppressor in Prostate Cancer
Figure 4
Cell cycle in PCa cells promoted by the knockdown of FOXO1. In LNCaP (a) and PC-3 (b) cells, cells’ percentage in the G1 phase was decreased and that in the S phase was increased by the knockdown of FOXO1. Significance holds if is below 0.05 (; ; ).
(a) |
(b) |